rs863225347
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000038.6(APC):c.3810T>A(p.Cys1270*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. CF1270C?) has been classified as Pathogenic.
Frequency
Consequence
NM_000038.6 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 33
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Familial adenomatous polyposis 1 Pathogenic:3
The APC c.3810T>A (p.Cys1270Ter) variant has been reported in several individuals affected with familial adenomatous polyposis (Kerr SE et al., PMID: 23159591; Su LK et al., PMID: 10982189; Wu G et al., PMID: 11960572). This variant has been reported in the ClinVar database as a germline pathogenic variant by six submitters and is absent from the general population (gnomAD v.2.1.1), indicating it is not a common variant. This variant causes a premature termination codon; however, because this occurs in the last exon, this is not predicted to lead to nonsense mediated decay, but is predicted to delete more than 1500 amino acids. Based on available information and the ACMG/AMP guidelines for variant interpretation (Richards S et al., PMID: 25741868), this variant is classified as pathogenic. -
ClinVar contains an entry for this variant (Variation ID: 217972). For these reasons, this variant has been classified as Pathogenic. A different truncation (p.Tyr2645Lysfs*14) that lies downstream of this variant has been determined to be pathogenic (PMID: 9824584, 1316610, 27081525, 8381579, 22135120, Invitae). This suggests that deletion of this region of the APC protein is causative of disease. This variant is expected to disrupt the EB1 and HDLG binding sites, which mediate interactions with the cytoskeleton (PMID: 15311282, 17293347). While functional studies have not been performed to directly test the effect on APC protein function, this suggests that disruption of the C-terminal portion of the protein is functionally important. This premature translational stop signal has been observed in individual(s) with familial adenomatous polyposis (PMID: 10982189, 23159591). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Cys1270*) in the APC gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 1574 amino acid(s) of the APC protein. -
This variant is considered pathogenic. This variant creates a termination codon and is predicted to result in premature protein truncation. -
not provided Pathogenic:3
The variant creates a premature nonsense codon, and is therefore predicted to result in the loss of a functional protein. Found in at least one patient with expected phenotype for this gene, and not found in general population data. -
- -
This variant is denoted APC c.3810T>A at the cDNA level and p.Cys1270Ter (C1270X) at the protein level. The substitution creates a nonsense variant, which changes a Cysteine to a premature stop codon (TGT>TGA), and is predicted to cause loss of normal protein function through protein truncation. APC Cys1270Ter results in the loss of 1574 amino acids and several protein domains are disrupted by the truncation (Azzopardi 2008, UniProt). This variant has been reported in individuals with adenomatous polyposis (Su 2000, Wu 2004, Kerr 2013) and is considered pathogenic. -
Familial multiple polyposis syndrome Pathogenic:1
Variant summary: APC c.3810T>A (p.Cys1270X) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein. Truncations downstream of this position have been classified as pathogenic by our laboratory and in ClinVar. The variant was absent in 250546 control chromosomes (gnomAD). c.3810T>A has been reported in the literature in individuals affected with Familial Adenomatous Polyposis (examples: Su_2000, Wu_2001, Kerr_2013, and Findlen_2021). These data indicate that the variant is very likely to be associated with disease. Four clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 and all classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. -
APC-related disorder Pathogenic:1
The APC c.3810T>A variant is predicted to result in premature protein termination (p.Cys1270*). This nonsense variant is located in the last exon of the APC gene and is expected to disrupt the last 1574 amino acid(s) of the APC protein. This variant has been reported in individuals with Familial Adenomatous Polyposis (examples: Kerr SE et al 2012. PubMed ID: 23159591). This variant has not been reported in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. This variant is interpreted as pathogenic in ClinVar (https://www.ncbi.nlm.nih.gov/clinvar/variation/217972/). This variant is interpreted as pathogenic. -
Hereditary cancer-predisposing syndrome Pathogenic:1
The p.C1270* pathogenic mutation (also known as c.3810T>A) located in coding exon 15 of the APC gene, results from a T to A substitution at nucleotide position 3810. This changes the amino acid from a cysteine to a stop codon within coding exon 15. This mutation has been previously identified in one kindred with FAP/AFAP (Su LK et al. Hum. Genet. 2000 Jan; 106(1):101-7). In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation. As such, this alteration is interpreted as a disease-causing mutation. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at